FAQ

What is the LUNG FORCE Lunch?

The LUNG FORCE Lunch is an informational talk and Q+A session on the latest in lung cancer research and stories of inspiration and resilience, featuring Dr. Jeffrey Kern.

How do I sign up?

You can register online by choosing the Register option in the navigation at the top of this page.

When is the Lunch?

The lunch is held on Wednesday September 18, at 11:30 AM.

Where is the Lunch?

The lunch will be hosted at Daniels Fund at 101 Monroe St in Denver, CO 80206.

"Bill Daniels established the Daniels Fund to operate in perpetuity as a permanent part of the communities we serve. Our assets — the source of our ability to provide grants and scholarships — were provided entirely by Bill. The annual return generated through careful investment of our assets creates our capacity for charitable giving while maintaining, or even growing, our asset base."

Where should I park?

From the Daniels Fund website:

"Daniels Fund is located in a residential neighborhood. Therefore, we ask our guests to be considerate of our neighbors by parking in our guest parking lot. Our guest parking lot is located at First Avenue and Madison Street, immediately to the west of our building. Enter from Madison Street. Parking is complimentary. The gate will open automatically upon entry or exit, and no code is needed.

Underground accessible parking is available upon request."

Who is Dr. Jeffrey Kern?

Jeffrey Kern, MD, is a pulmonologist at National Jewish Health. Dr. Kern serves as Chief of the Division of Oncology, Cancer Center. Dr. Kern is an expert in how cells in the lung grow, focusing on a family of proteins that regulate cell growth by transmitting signals outside the cell to the inside. These proteins play an important role in keeping a cell’s growth in check. When these proteins malfunction, abnormal growth ensues which can result in lung cancer. Dr. Kern’s research tries to understand how these protein signals are regulated, discover molecules that interfere with this process and might be used as chemotherapy, and discover new proteins regulating cell growth. If you would like to know more about Dr. Kern, please see his profile on National Jewish Health’s website. It can be found here.